1st Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,668,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to tax reform.

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
AMY L REDL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Biodefence appropriation issues related to Biomedical Advanced Research and Development Authority (BARDA)

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
AMY L REDL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Torts TOR

Issues related to S.340 "CREATES Act of 2019".

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 340 (116th)

Copyright/Patent/Trademark CPT

Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S.344 "Hatch-Waxman Integrity Act of 2019".

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
ELIZABETH STOWER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 344 (116th)

Health Issues HCR

Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation; issues related to S. 97 " Affordable and Safe Prescription Drug Importation Act"; issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to dietary supplements; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 102 (116th), H.R. 269 (116th), S. 97 (116th)

Medicare/Medicaid MMM

Issues related to S.99 "Medicare Drug Price Negotiation Act"

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 99 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.